• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽酰精氨酸脱亚氨酶 1 催化的组蛋白瓜氨酸化对于早期胚胎发育至关重要。

Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development.

机构信息

State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.

Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, China.

出版信息

Sci Rep. 2016 Dec 8;6:38727. doi: 10.1038/srep38727.

DOI:10.1038/srep38727
PMID:27929094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5144008/
Abstract

Peptidylarginine deiminase (PADI) enzymes are increasingly being associated with the regulation of chromatin structure and gene activity via histone citrullination. As one of the PADI family members, PADI1 has been mainly reported to be expressed in the epidermis and uterus, where the protein in keratinocytes is thought to promote differentiation by citrullinating filament proteins. However, the roles of PADI1 in preimplantation development have not been addressed. Using a PADI1-specific inhibitor and Padi1-morpholino knockdown, we found that citrullination of histone tails at H4R3 and H3R2/8/17 were markedly reduced in the 2- and 4-cell embryos. Consistent with this observation, early embryo development was also arrested at the 4-cell stage upon depletion of PADI1 or inhibition of PADI1 enzyme activity. Additionally, by employing 5-ethynyl uridine (EU) incorporation analysis, ablation of PADI1 function led to a dramatic decrease in overall transcriptional activity, correlating well with the reduced levels of phosphorylation of RNA Pol II at Ser2 observed at 2- or 4-cell stage of embryos under Padi1 knockdown or inhibiting PADI1. Thus, our data reveal a novel function of PADI1 during early embryo development transitions by catalyzing histone tail citrullination, which facilitates early embryo genome transactivation.

摘要

肽基精氨酸脱亚氨酶(PADI)酶通过组蛋白瓜氨酸化,越来越多地与染色质结构和基因活性的调节相关联。作为 PADI 家族成员之一,PADI1 主要在表皮和子宫中表达,角质形成细胞中的蛋白质被认为通过瓜氨酸化丝氨酸来促进分化。然而,PADI1 在着床前发育中的作用尚未得到解决。使用 PADI1 特异性抑制剂和 Padi1- 吗啉代寡核苷酸敲低,我们发现 H4R3 和 H3R2/8/17 组蛋白尾部的瓜氨酸化在 2- 和 4- 细胞胚胎中明显减少。与这一观察结果一致,在 PADI1 耗尽或抑制 PADI1 酶活性时,早期胚胎发育也在 4- 细胞阶段停滞。此外,通过 5- 乙炔基尿苷(EU)掺入分析,PADI1 功能的缺失导致整体转录活性显著下降,与在 Padi1 敲低或抑制 PADI1 时在 2- 或 4- 细胞期胚胎中观察到的 RNA Pol II Ser2 磷酸化水平降低密切相关。因此,我们的数据揭示了 PADI1 在早期胚胎发育过渡中通过催化组蛋白尾部瓜氨酸化的新功能,从而促进早期胚胎基因组转录激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/7a80a2a12371/srep38727-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/f7790e1919fb/srep38727-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/73c80da1aaad/srep38727-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/2bddcff01985/srep38727-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/5cbc8e2a6ed8/srep38727-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/7a80a2a12371/srep38727-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/f7790e1919fb/srep38727-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/73c80da1aaad/srep38727-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/2bddcff01985/srep38727-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/5cbc8e2a6ed8/srep38727-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df0a/5144008/7a80a2a12371/srep38727-f5.jpg

相似文献

1
Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development.肽酰精氨酸脱亚氨酶 1 催化的组蛋白瓜氨酸化对于早期胚胎发育至关重要。
Sci Rep. 2016 Dec 8;6:38727. doi: 10.1038/srep38727.
2
Potential role for PADI-mediated histone citrullination in preimplantation development.肽基精氨酸脱亚胺酶介导的组蛋白瓜氨酸化在植入前发育中的潜在作用。
BMC Dev Biol. 2012 Jun 19;12:19. doi: 10.1186/1471-213X-12-19.
3
Crucial roles of MZF1 and Sp1 in the transcriptional regulation of the peptidylarginine deiminase type I gene (PADI1) in human keratinocytes.MZF1和Sp1在人角质形成细胞中I型肽基精氨酸脱亚氨酶基因(PADI1)转录调控中的关键作用。
J Invest Dermatol. 2008 Mar;128(3):549-57. doi: 10.1038/sj.jid.5701048. Epub 2007 Sep 13.
4
Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation.肽基精氨酸脱亚氨酶 2 催化的组蛋白 H3 精氨酸 26 瓜氨酸化促进雌激素受体 α 靶基因激活。
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13331-6. doi: 10.1073/pnas.1203280109. Epub 2012 Aug 1.
5
Methods for analyzing histone citrullination in chromatin structure and gene regulation.分析染色质结构和基因调控中组蛋白瓜氨酸化的方法。
Methods Mol Biol. 2012;809:473-88. doi: 10.1007/978-1-61779-376-9_31.
6
Citrullination regulates pluripotency and histone H1 binding to chromatin.瓜氨酸化调控多能性和组蛋白 H1 与染色质的结合。
Nature. 2014 Mar 6;507(7490):104-8. doi: 10.1038/nature12942. Epub 2014 Jan 26.
7
Localization and expression of peptidylarginine deiminase 4 (PAD4) in mammalian oocytes and preimplantation embryos.肽基精氨酸脱亚氨酶4(PAD4)在哺乳动物卵母细胞和植入前胚胎中的定位与表达
Zygote. 2013 Nov;21(4):314-24. doi: 10.1017/S0967199411000633. Epub 2011 Nov 30.
8
GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.促性腺激素释放激素刺激促性腺激素细胞中肽基精氨酸脱亚氨酶催化的组蛋白瓜氨酸化。
Mol Endocrinol. 2016 Oct;30(10):1081-1091. doi: 10.1210/me.2016-1085. Epub 2016 Sep 7.
9
Long-range enhancer differentially regulated by c-Jun and JunD controls peptidylarginine deiminase-3 gene in keratinocytes.由c-Jun和JunD差异调控的远程增强子控制角质形成细胞中的肽基精氨酸脱亚氨酶-3基因。
J Mol Biol. 2008 Dec 31;384(5):1048-57. doi: 10.1016/j.jmb.2008.10.019. Epub 2008 Oct 15.
10
An intronic enhancer driven by NF-κB contributes to transcriptional regulation of peptidylarginine deiminase type I gene in human keratinocytes.NF-κB 驱动的内含子增强子有助于人角质形成细胞中肽基精氨酸脱亚氨酶 I 基因的转录调控。
J Invest Dermatol. 2010 Nov;130(11):2543-52. doi: 10.1038/jid.2010.179. Epub 2010 Jul 1.

引用本文的文献

1
A comprehensive review of histone modifications during mammalian oogenesis and early embryo development.哺乳动物卵子发生和早期胚胎发育过程中组蛋白修饰的综合综述。
Histochem Cell Biol. 2025 Jun 28;163(1):70. doi: 10.1007/s00418-025-02398-x.
2
Citrullination in health and disease: From physiological function to gene regulation.健康与疾病中的瓜氨酸化:从生理功能到基因调控。
Genes Dis. 2024 Jun 22;12(4):101355. doi: 10.1016/j.gendis.2024.101355. eCollection 2025 Jul.
3
Fine-mapping causal tissues and genes at disease-associated loci.

本文引用的文献

1
Involvement of Rab6a in organelle rearrangement and cytoskeletal organization during mouse oocyte maturation.Rab6a在小鼠卵母细胞成熟过程中参与细胞器重排和细胞骨架组织。
Sci Rep. 2016 Mar 31;6:23560. doi: 10.1038/srep23560.
2
Oocyte-expressed yes-associated protein is a key activator of the early zygotic genome in mouse.卵母细胞表达的Yes相关蛋白是小鼠早期合子基因组的关键激活因子。
Cell Res. 2016 Mar;26(3):275-87. doi: 10.1038/cr.2016.20. Epub 2016 Feb 23.
3
A localized nucleolar DNA damage response facilitates recruitment of the homology-directed repair machinery independent of cell cycle stage.
在疾病相关位点精细定位因果组织和基因。
Nat Genet. 2025 Jan;57(1):42-52. doi: 10.1038/s41588-024-01994-2. Epub 2025 Jan 2.
4
Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease.蛋白质组学对外细胞基质的研究进展:重点关注蛋白质形式及其在健康和疾病中的意义。
Expert Rev Proteomics. 2024 Nov;21(11):463-481. doi: 10.1080/14789450.2024.2427136. Epub 2024 Nov 15.
5
Brain-Region-Specific Differences in Protein Citrullination/Deimination in a Pre-Motor Parkinson's Disease Rat Model.大脑区域特异性蛋白瓜氨酸化/脱亚胺化在运动前期帕金森病大鼠模型中的差异。
Int J Mol Sci. 2024 Oct 17;25(20):11168. doi: 10.3390/ijms252011168.
6
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases.跨越表观遗传学前沿:新型组蛋白修饰与疾病的交汇点。
Signal Transduct Target Ther. 2024 Sep 16;9(1):232. doi: 10.1038/s41392-024-01918-w.
7
A quantitative and site-specific atlas of the citrullinome reveals widespread existence of citrullination and insights into PADI4 substrates.一种定量且特定部位的瓜氨酸组图谱揭示了瓜氨酸化的广泛存在,并深入了解了 PADI4 的底物。
Nat Struct Mol Biol. 2024 Jun;31(6):977-995. doi: 10.1038/s41594-024-01214-9. Epub 2024 Feb 6.
8
Fine-mapping causal tissues and genes at disease-associated loci.在疾病相关位点精细定位因果组织和基因。
medRxiv. 2024 Jun 17:2023.11.01.23297909. doi: 10.1101/2023.11.01.23297909.
9
Transcriptomic analysis of PADI4 target genes during multi-lineage differentiation of embryonic stem cells.胚胎干细胞多能性分化过程中 PADI4 靶基因的转录组分析。
Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220236. doi: 10.1098/rstb.2022.0236. Epub 2023 Oct 2.
10
PADI6: What we know about the elusive fifth member of the peptidyl arginine deiminase family.PADI6:关于肽基精氨酸脱亚氨酶家族中难以捉摸的第五个成员,我们所知道的。
Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220242. doi: 10.1098/rstb.2022.0242. Epub 2023 Oct 2.
局部核仁DNA损伤反应促进同源定向修复机制的募集,且不依赖于细胞周期阶段。
Genes Dev. 2015 Jun 1;29(11):1151-63. doi: 10.1101/gad.260703.115. Epub 2015 May 27.
4
Involvement of histone H2B monoubiquitination in the regulation of mouse preimplantation development.组蛋白H2B单泛素化参与小鼠植入前胚胎发育的调控
J Reprod Dev. 2015;61(3):179-84. doi: 10.1262/jrd.2014-137. Epub 2015 Feb 6.
5
Zygotic genome activation during the maternal-to-zygotic transition.母源-合子转变过程中的合子基因组激活
Annu Rev Cell Dev Biol. 2014;30:581-613. doi: 10.1146/annurev-cellbio-100913-013027. Epub 2014 Aug 11.
6
Citrullination regulates pluripotency and histone H1 binding to chromatin.瓜氨酸化调控多能性和组蛋白 H1 与染色质的结合。
Nature. 2014 Mar 6;507(7490):104-8. doi: 10.1038/nature12942. Epub 2014 Jan 26.
7
PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expression.PAD4 通过控制 c-myc 表达调节多能造血细胞的增殖。
Nat Commun. 2013;4:1836. doi: 10.1038/ncomms2862.
8
Epigenetic programming and reprogramming during development.发育过程中的表观遗传编程和重编程。
Nat Struct Mol Biol. 2013 Mar;20(3):282-9. doi: 10.1038/nsmb.2489. Epub 2013 Mar 5.
9
D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.基于D-氨基酸的蛋白质精氨酸脱亚氨酶抑制剂:合成、药代动力学及细胞内疗效
ACS Med Chem Lett. 2012 Oct 26;3(12):1081-1085. doi: 10.1021/ml300288d.
10
The maternal to zygotic transition in mammals.哺乳动物的母源到合子的过渡。
Mol Aspects Med. 2013 Oct;34(5):919-38. doi: 10.1016/j.mam.2013.01.003. Epub 2013 Jan 23.